Coronavrus: Bolsonaro rules out buying “vaccine from China” and contradicts the argument



[ad_1]

Update (10/21/2020) – RB

The day after the Federal Government confirmed the purchase of 46 million doses of CoronaVac, President Jair Bolsonaro declared that he would not announce the acquisition by the Ministry of Health. This candidate – created by the private laboratory Sinovac – has been tested by the Butantan Institute. , with the approval of the Governor of São Paulo, João Doria.

According to Bolsonaro, the government would only buy drugs effectively “Scientifically tested by the Ministry of Health and certified by Anvisa”. It is worth remembering that the results of the CoronaVac effectiveness tests have not yet been published, but the previous data shows a safety level of over 98%.

“For my government, any vaccine, before being made available to the population, must be scientifically tested by the Ministry of Health and certified by Anvisa. The Brazilian people will not be anyone’s guinea pig. There is no justification for a multi-million dollar financial contribution to a drug that has not even passed its testing phase. Given the above, my decision is not to buy the vaccine ”.

Jair bolsonaro

Republic President

The president would have even sent a message to the ministers, with the declaration that “We will not buy vaccines from China”, as reported by the website Power 360.

Contradiction

Despite having declared that it would not buy the Chinese vaccine because it does not have proven efficacy or authorization from Anvisa, the Brazilian government has already opted for other initiatives that did not meet these requirements either.

One of them was the production of 18 years of chloroquine stock by the Army in a few months, for more than R $ 1.5 million, under investigation by the Public Ministry and the Federal Court of Accounts (TCU). The drug was revoked in the United States, banned from the Albert Einstein Hospital, and its effectiveness was ruled out by the World Health Organization (WHO).

Coronav


Security
21 Out

Coronav


Security
20 Out

Another was the purchase of 100 million doses of the Oxford vaccine, for R $ 1.9 billion. She, in addition to not being authorized by Anvisa, is still in Phase 3 of the clinical study -the same as in CoronaVac-, but should only be ready after the candidate experienced by the Butantan Institute.

So, do you agree with Bolsonaro’s decision or would you like the Ministry of Health to finalize the purchase of the Butantan and Sinovac vaccine? Write your review!

Original text (10/20/2020)

Coronavirus: Federal Government closes contract to buy 46 million doses of CoronaVac

The Federal Government has just announced the acquisition of 46 million doses of CoronaVac through SUS. The vaccine has been developed and tested by the Chinese pharmaceutical company SinoVac in association with the Government of the State of São Paulo and the Butantan Institute.

The news comes a day after the press conference led by Governor João Doria and the hematologist and director of the Butantan Institute Dimas Covas in which preliminary data on CoronaVac’s safety were released. According to the doctor, CoronaVac is the vaccine that has the safest profile among all those tested against COVID-19, with the most common side effect, headache (headache), affecting only 15% of volunteers.

Xiaomi lan


Economy and market
13 Out

Coronav


Security
07 Out

Even during the press conference, João Doria said that negotiations with the Union were underway, with a meeting to resolve the details of the production and distribution operation scheduled with the Minister of Health, Eduardo Pazuello, for this Wednesday (21) . At today’s meeting, which defined the purchase of the vaccine, the heads of 23 other states in the country were also present.

Vaccination with CoronaVac is expected to begin in January 2021, and is included in the National Immunization Calendar, without priority for residents of the State of São Paulo. Despite this, as Dimas Covas warned, the calendar may be delayed. According to the doctor, the last stage of the tests is paralyzed by the lack of elderly volunteers. “We need proof of the efficacy of the vaccine in at least 61 cases. It is statistically possible, but we have no control over reality, ”he said.

[ad_2]